Postmortem implantable cardioverter defibrillator interrogation

Paul A. Friedman, Charles D. Swerdlow

Research output: Chapter in Book/Report/Conference proceedingChapter


The 78-year-old man described in previous case 169 is followed. No programming was performed at an August 2007 visit. Instead, amiodarone therapy was initiated to prevent asymptomatic VT requiring termination by antitachycardia pacing. Six weeks later, on September 28, 2007, the patient developed rapid palpitations after receiving bad news. Within a few minutes, he experienced dyspnea and his typical angina. He used nitroglycerin spray twice without relief. Twenty minutes later he collapsed and died. Steps that could have been taken to prevent the patient’s death are discussed.

Original languageEnglish (US)
Title of host publicationCardiac Electrophysiology
Subtitle of host publicationClinical Case Review
PublisherSpringer International Publishing
Number of pages2
ISBN (Electronic)9783030285333
ISBN (Print)9783030285319
StatePublished - Jan 1 2020


  • Amiodarone
  • ICD
  • Nitroglycerin

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Postmortem implantable cardioverter defibrillator interrogation'. Together they form a unique fingerprint.

Cite this